Kauvery Hospital Alwarpet Introduces CAR-T Cell Therapy for Cancer Treatment
Chennai: Kauvery Hospital, Alwarpet, a leading multi-specialty healthcare provider in Chennai, has launched Chimeric Antigen Receptor T-cell (CAR-T) therapy, a groundbreaking treatment for certain blood cancers.
What is CAR-T Therapy?
CAR-T therapy is a type of immunotherapy that uses a patient’s own immune cells, called T cells, to fight cancer. The T cells are modified in a lab to recognize and attack cancer cells, and then infused back into the patient’s body.
Benefits and Applications
- Targeted Treatment: CAR-T therapy provides a more targeted and personalized approach to treating blood cancers like acute lymphoblastic leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL).
- Treatment for Resistant Cancers: This therapy is especially useful for patients who have not responded to conventional therapies.
- Ongoing Protection: The modified T cells can multiply and stay active in the body, providing ongoing protection against cancer relapse.
Quotes from Kauvery Hospital
- Dr. Arshad Raja, Consultant Hemato-Oncologist: “CAR-T therapy changes how we treat hematologic cancers… we are empowering patients in India with world-class, precision-targeted care that was once out of reach.”
- Dr. Aravindan Selvaraj, Executive Director and Co-Founder: “The launch of CAR-T therapy marks a bold step into the future of medicine… our passion for innovation, our pursuit of excellence, and our mission to change lives for the better.”